Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study
Cornea, 08/17/2012
Clinical Article
Benayoun Y et al. – Short–term results suggest that subconjunctival bevacizumab can be used safely and effectively for corneal neovascularization resulting from different ocular surface disorders, providing an additional strategy to improve success of corneal grafts.



